Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Mérieux Equity Partners has outlined its approach to investing in Lithuania and wider Europe, highlighting a particular focus ...

The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.

Patients will now be able to access BMS' Sotyktu for significantly cheaper than current list prices, alongside BMS and Pfizer ...

Share price in Harmony tumbled in the wake of the Phase III trial miss, with a route to market for ZYN002 looking bleak.

After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...

Moderna has opened its new vaccine manufacturing and R&D facility in Oxfordshire, UK, the Moderna Innovation and Technology ...

Sanofi has committed an additional $625m to its venture capital arm, Sanofi Ventures, bringing its total assets under ...

There’s been another detour in tolebrutinib’s path to market, with developer Sanofi revealing that the US Food and Drug ...